Mark Leschly
Director, Senomyx.
Companies
- ChargePointBoard member Mar 2, 2021 to now1
- NGM Biopharmaceuticals (United States)Board member Apr 3, 2019 to Jun 10, 20212
- Verenium CorporationBoard member Jul 24, 2006 to Feb 18, 20093
- TercicaBoard member Jun 16, 2006 to Oct 20, 20084
- SenomyxBoard member Jan 30, 2006 to Jun 4, 20075
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Recent filings
- Jul 21, 2026Granted 1,336 shares of CIK 17773936
- Jul 21, 2026Granted 6,680 shares of CIK 17773936
- Jul 21, 2026Granted 18,370 shares of CIK 17773936
- Jul 8, 2025Granted 254,785 shares of CIK 17773937
- Jul 9, 2024Granted 115,552 shares of CIK 17773938
- Jul 18, 2023Granted 21,925 shares of CIK 17773939
- Jul 12, 2022Granted 13,563 shares of CIK 177739310
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARChargePoint, Board member
- 2
- 3SEC EDGARVerenium Corporation, Board member
- 4SEC EDGARTercica, Board member
- 5SEC EDGARSenomyx, Board member
- 6SEC EDGARForm 4 filed Jul 22, 2026
- 7SEC EDGARForm 4 filed Jul 9, 2025
- 8SEC EDGARForm 4 filed Jul 11, 2024
- 9SEC EDGARForm 4 filed Jul 20, 2023
- 10SEC EDGARForm 4 filed Jul 14, 2022